Methylprednisolone Recruiting Phase 2 Trials for Graft Versus Host Disease, Acute Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01589549Mesenchymal Stromal Cells for Acute Graft Versus Host Disease
NCT02133924Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease